{
    "symbol": "PASG",
    "quarter": 1,
    "year": 2022,
    "date": "2022-05-16 14:07:09",
    "content": "  Before we begin, please note that today\u2019s call may include a number of forward-looking statements, including, but not limited to, comments on our expectations about timing and execution of anticipated milestones, including the initiation of clinical trials and the availability of clinical data from such trials; our expectations about our collaborators and partners\u2019 ability to execute key initiatives; the ability of our lead product candidates to treat their respective target CNS disorder; manufacturing plans and strategies; trends with respect to financial performance and cash flows; the Company\u2019s ability to fund research and development programs; impacts of the COVID-19 pandemic on the Company\u2019s operations; and its ability to manage costs, along with uses of cash and other matters."
}